PART B CODING COACH: CPT 2010 Preview: Getting Paid Per Drug Class for Test Kits? That's About to End

Subscribe or sign in to view the full article.

Note:  The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.

Article Overview

This article explains a proposed shift in how Medicare pays for laboratory drug screen testing and why the change matters for labs that bill these services. It covers the move from existing CPT drug screen codes to new HCPCS G codes, the role of CLIA-waived testing, and the CMS process for proposed and final payment determinations. The piece is aimed at laboratory coders, billing staff, and compliance professionals following 2010 coding updates and fee schedule changes.

Why This Topic Matters

The article helps readers understand upcoming Medicare payment changes for drug screen testing and the administrative steps tied to CMS pricing. It is relevant to labs that need to track code transitions, payment updates, and public comment timelines.

Article Sections

  1. Drug screen payment issue

    Introduces the Medicare payment concern affecting laboratory drug screen testing and the broader context for the proposed changes.

  2. Drug screens aren't equal

    Explains the current coding landscape for drug screen testing and the category of laboratory services involved.

  3. Problem

    Describes the existing CPT framework used for billing drug screen services and the related CLIA-waived testing context.

  4. G Codes Create Drug Class Division

    Covers the proposed HCPCS G code replacement structure and the CMS rationale for separating categories of drug screening services.

  5. Heads up for pay changes

    Addresses anticipated fee schedule effects and the possibility of changes to existing Medicare payment handling.

  6. Comment on Pricing Proposal by October

    Summarizes CMS timing for proposed payment postings, public comments, and final determinations.

  7. Expect crosswalk

    Notes the Medicare pricing methodologies discussed for the new codes and the general preference reported at the public meeting.

What You Will Learn

  • How Medicare payment policy is changing for laboratory drug screen testing
  • Which code families are involved in the transition from existing CPT codes to HCPCS G codes
  • How CLIA-waived testing fits into the broader coding discussion
  • What CMS timing and comment opportunities are associated with the proposed pricing
  • What general payment methodologies are being discussed for the new codes

Who Should Read This

  • Laboratory coders
  • Medical billers
  • Revenue cycle staff
  • Compliance professionals
  • Clinical laboratory administrators

Codes Discussed

Modifiers Discussed


Subscribe or sign in to view the full article.

Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

Related Articles

Articles are listed in order of calculated relevance.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?